326 related articles for article (PubMed ID: 32448369)
1. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database.
Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N
BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Chisaki Y; Aoji S; Yano Y
Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
[TBL] [Abstract][Full Text] [Related]
3. Quality evaluation of the Japanese Adverse Drug Event Report database (JADER).
Tsuchiya M; Obara T; Sakai T; Nomura K; Takamura C; Mano N
Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):173-181. PubMed ID: 31823506
[TBL] [Abstract][Full Text] [Related]
4. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
[TBL] [Abstract][Full Text] [Related]
5. Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs.
Dubrall D; Leitzen S; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B
BMC Pharmacol Toxicol; 2021 Oct; 22(1):56. PubMed ID: 34620231
[TBL] [Abstract][Full Text] [Related]
6. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
Nagai J; Ishikawa Y
PLoS One; 2021; 16(12):e0260980. PubMed ID: 34855908
[TBL] [Abstract][Full Text] [Related]
7. The quality assessment of the Japanese Adverse Drug Event Report database using vigiGrade.
Tsuchiya M; Obara T; Miyazaki M; Noda A; Takamura C; Mano N
Int J Clin Pharm; 2020 Apr; 42(2):728-736. PubMed ID: 32020439
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy in elderly patients in Japan: Analysis of Japanese real-world databases.
Mabuchi T; Hosomi K; Yokoyama S; Takada M
J Clin Pharm Ther; 2020 Oct; 45(5):991-996. PubMed ID: 31986233
[TBL] [Abstract][Full Text] [Related]
9. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions in older adults: a retrospective comparative analysis of spontaneous reports to the German Federal Institute for Drugs and Medical Devices.
Dubrall D; Just KS; Schmid M; Stingl JC; Sachs B
BMC Pharmacol Toxicol; 2020 Mar; 21(1):25. PubMed ID: 32293547
[TBL] [Abstract][Full Text] [Related]
11. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K
Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819
[TBL] [Abstract][Full Text] [Related]
12. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.
Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM
Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
15. Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.
Ohta M
Eur J Clin Pharmacol; 2021 Oct; 77(10):1443-1452. PubMed ID: 33829295
[TBL] [Abstract][Full Text] [Related]
16. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
[TBL] [Abstract][Full Text] [Related]
17. Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
Sato K; Mano T; Iwata A; Toda T
J Alzheimers Dis; 2021; 82(3):1333-1344. PubMed ID: 34151816
[TBL] [Abstract][Full Text] [Related]
18. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical adverse drug reactions: descriptive analysis of French reports.
Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
[TBL] [Abstract][Full Text] [Related]
20. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
